ANGELA MAE ROMAN: Open Payments
NPI 1992360036 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 12 payments from 9 companies in 2025. Trend: 2023 $630 · 2024 $885 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $66 |
| Boston Scientific Corporation | 3 | $65 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
Products named: AMVUTTRA, WATCHMAN FLX, VERQUVO, DEFINITY, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ACCOLADE SR, UPTRAVI, FARXIGA.
Industry payments across CA — which companies pay providers there.
